X | ||||||||||
- Definition Weighted Average Remaining Contractual Life (in years), Exercisable. No definition available.
|
X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award, non-option equity instruments, exercisable. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price outstanding. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price exercisable. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price, Exercised. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price, Forfeited/Cancelled. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price, granted. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|